Finance

Lists
NWBO:OTCMKTS
Northwest Biotherapeutics Inc
0,16 US$
-1,53%
(-0,0025) 1D
14 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NWBO...
Open
0,16 US$
High
0,17 US$
Low
0,16 US$
Mkt. cap
277,15 მლნ.
Avg. vol.
3,89 მლნ.
Volume
5,33 მლნ.
52-wk high
0,34 US$
52-wk low
0,14 US$
EPS
-0,03 US$
Beta
-0,62
Shares outstanding
1,71 მლრდ.
No. of employees
105
Open
0,16 US$
High
0,17 US$
Low
0,16 US$
Mkt. cap
277,15 მლნ.
Avg. vol.
3,89 მლნ.
Volume
5,33 მლნ.
52-wk high
0,34 US$
52-wk low
0,14 US$
EPS
-0,03 US$
Beta
-0,62
Shares outstanding
1,71 მლრდ.
No. of employees
105
News stories
From web sources and news partners
Profile
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
About Northwest Biotherapeutics Inc
CEO-
Employees105
Founded1 იან. 1998
Headquarters-
Sector-
Websitenwbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
200,00 ათ.
672,00 ათ.
494,00 ათ.
807,00 ათ.
Cost of goods sold
7,45 მლნ.
5,55 მლნ.
4,86 მლნ.
5,70 მლნ.
Cost of revenue
7,45 მლნ.
5,55 მლნ.
4,86 მლნ.
5,70 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,07 მლნ.
8,62 მლნ.
6,54 მლნ.
6,71 მლნ.
Operating expense
7,07 მლნ.
8,62 მლნ.
6,54 მლნ.
6,71 მლნ.
Total operating expenses
14,52 მლნ.
14,18 მლნ.
11,39 მლნ.
12,41 მლნ.
Operating income
-14,32 მლნ.
-13,50 მლნ.
-10,90 მლნ.
-11,60 მლნ.
Other non operating income
-3,45 მლნ.
1,14 მლნ.
9,53 მლნ.
64,00 ათ.
EBT including unusual items
-26,83 მლნ.
851,00 ათ.
-3,07 მლნ.
-9,22 მლნ.
EBT excluding unusual items
-21,20 მლნ.
-14,82 მლნ.
-5,06 მლნ.
-13,47 მლნ.
Income tax expense
-
-537,00 ათ.
-
-
Effective tax rate
-
-63,10%
-
-
Other operating expenses
-
-
-
-
Net income
-26,83 მლნ.
1,39 მლნ.
-3,07 მლნ.
-9,22 მლნ.
Net profit margin
-13 414,50%
206,55%
-621,25%
-1 142,63%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2,62 მლნ.
-2,65 მლნ.
-2,35 მლნ.
-1,81 მლნ.
Net interest expenses
-2,62 მლნ.
-2,65 მლნ.
-2,35 მლნ.
-1,81 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,87 მლნ.
-12,78 მლნ.
-10,13 მლნ.
-10,83 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები